Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
LDLR- |
RCV000237615 | SCV000295925 | likely benign | Hypercholesterolemia, familial, 1 | 2016-03-25 | criteria provided, single submitter | literature only | |
Illumina Laboratory Services, |
RCV000237615 | SCV000410544 | uncertain significance | Hypercholesterolemia, familial, 1 | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. |
Robarts Research Institute, |
RCV000237615 | SCV000484755 | uncertain significance | Hypercholesterolemia, familial, 1 | 2019-08-22 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV001178125 | SCV001342485 | likely benign | Familial hypercholesterolemia | 2021-03-02 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001178125 | SCV001531711 | likely benign | Familial hypercholesterolemia | 2024-01-15 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV000237615 | SCV003816522 | uncertain significance | Hypercholesterolemia, familial, 1 | 2022-03-31 | criteria provided, single submitter | clinical testing | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000162012 | SCV004219974 | uncertain significance | not provided | 2023-05-23 | criteria provided, single submitter | clinical testing | In the published literature, this variant has been reported in individuals with suspected to severe hypercholesterolemia (PMIDs: 27765764 (2016), 27044878 (2017), 32044282 (2020)) and individuals with early-onset myocardial infarction (PMIDs: 25647241 (2015) and 25487149 (2015)). An in vitro functional study indicated an inconclusive effect of this variant on LDLR function (PMID: 25647241 (2015)). The frequency of this variant in the general population, 0.00052 (16/30616 chromosomes (Genome Aggregation Database, http://gnomad.broadinstitute.org)), is uninformative in the assessment of its pathogenicity. Analysis of this variant using bioinformatics tools for the prediction of the effect of amino acid changes on protein structure and function yielded predictions that this variant is benign. Based on the available information, we are unable to determine the clinical significance of this variant. |
Dept. |
RCV000162012 | SCV000189588 | not provided | not provided | no assertion provided | in vitro | ||
Laboratorium voor Moleculaire Diagnostiek Experimentele Vasculaire Geneeskunde, |
RCV000237615 | SCV000606618 | pathogenic | Hypercholesterolemia, familial, 1 | no assertion criteria provided | research | ||
Natera, |
RCV001178125 | SCV002086870 | uncertain significance | Familial hypercholesterolemia | 2020-02-25 | no assertion criteria provided | clinical testing |